ENTITY
Grifols

Grifols (GRFS US)

19
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bearishGrifols SA
29 Oct 2024 06:45

Brookfield Delays Its Takeover Bid for Grifols for a Second Time

Brookfield’s acquisition bid for Grifols has been delayed for a second time due to funding issues, raising investor concerns.

Share
16 Oct 2024 20:13

Liquid Universe of European Ordinary and Preferred Shares: October‘24 Report

Since mid-September, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have...

Share
04 Oct 2024 16:57

SSI Newsletter: September Performance, TBNK Merger Arbitrage, OCI Asset Sale, MMLP Privatization

SSI Tracking Portfolio decreased by 0.7% in September but has increased by 8.4% year-to-date, with a detailed performance breakdown available.

bullishGrifols SA
21 Sep 2024 00:30

Brookfield/Grifols: Recap and Analysis of Latest Developments

Since Brookfield's July 8 takeover interest for Grifols was announced, the situation has become complicated, with unclear pricing, funding...

Share
bullishHenkel & KGaA
17 Sep 2024 23:58

Liquid Universe of European Ordinary and Preferred Shares: September‘24 Report

Since mid-August, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (13 have...

Share
x